Sandbox c16
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease. | It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease. | ||
| - | + | <scene name='Sandbox_c16/Modificacion_2/1'>Tacrine´s</scene> ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (<scene name='Sandbox_c16/Modificacion_1/1'>W84 and F330</scene> ). | |
| - | < | + | <references/> |
Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding | Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding | ||
| - | [http://www.pubmed.com publicaciones medicas] | + | [http://www.pubmed.com publicaciones medicas] <references/> <ref>PMDI 8415649</ref> |
Revision as of 13:23, 23 November 2010
Estructura acetilcolinesterasa
|
1ACJ shows the crystal structure of Torpedo californica acetylcholinesterase (TcAChE) complexed with tacrine. Tacrine is a parasympathomimetic and a centrally acting cholinesterase inhibitor.
It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 ( ).
Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding
publicaciones medicas [1]
